← Eichor
Study identifier: NCT06639373 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

The Road to Recovery Initiative (R2RI)

Condition: Substance-Related Disorders  ·  Sponsor: BC Centre on Substance Use

PhaseN/A
Planned participants10000
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

Despite substance use causing significant harms and cost to our health care system, British Columbia's (BC) current addiction treatment system remains under-resourced and fragmented. To address this, Providence Health Care (PHC) is expanding clinical addiction services as part of the Road to Recovery Initiative (R2R). The proposed study aims to generate novel data to promote fully evidence-informed and coordinated substance use care in BC and beyond. This study will explore substance use treatment trajectories, identify challenges and areas for growth in addiction health services, characterize important features of patients accessing care, and improve our provincial capacity to promptly tailor approaches to care in response to the substance use crisis.

This description comes directly from the study's public registry record.

Talk to the study team

Seonaid Nolan, MD, FRCPC  ·  604-682-2344  ·  seonaid.nolan@bccsu.ubc.ca

Always discuss trial participation with your own doctor first.

Locations (1)

St. Paul's Hospital - Providence Health CareVancouver, British Columbia, CanadaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06639373